Literature DB >> 35168638

Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial.

Javed Akram1, Shehnoor Azhar2, Muhammad Shahzad3, Waqas Latif4, Khalid Saeed Khan5.   

Abstract

Entities:  

Year:  2022        PMID: 35168638      PMCID: PMC8845337          DOI: 10.1186/s13063-022-06080-8

Source DB:  PubMed          Journal:  Trials        ISSN: 1745-6215            Impact factor:   2.279


× No keyword cloud information.
Correction to: Trials 21, 702 (2020) https://doi.org/10.1186/s13063-020-04616-4 Following the publication of the original article [1], we were notified of the below corrections: 1- In the Intervention and Comparator section, Phosphate is erroneously mentioned. 2- In the Participants section, “Participants of any gender or age group having tested positive” should read “Participants of either gender above 18 years of age”.

北京卡尤迪生物科技股份有限公司 © 2022-2023.